Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cansino Biologics Inc (OP: CASBF )

2.830 +0.730 (+34.76%)
Streaming Delayed Price Updated: 2:00 PM EDT, May 28, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 500
Open 2.865
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 2.100
Today's Range 2.830 - 2.865
52wk Range 1.860 - 3.950
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Week In Review: BeiGene And Bristol-Myers Squibb Close BeiGene-Celgene PD-1 Partnership
BeiGene and Bristol-Myers Squibb have formally completed the breakup of the BeiGene-Celgene partnership, returning 23.3 million ordinary BeiGene shares to BeiGene. Meanwhile, Gracell Biotechnologies... 
Via Talk Markets
Why Is CanSino Biologics (CASBF) Stock Soaring Today?
CanSino Biologics shares are ripping higher on Wednesday, with CASBF stock up more than 75%. The move comes as China pushes for more vaccines. 
Via InvestorPlace

Performance

YTD
+5.79%
+5.79%
1 Month
N/A
N/A
3 Month
+23.31%
+23.31%
6 Month
-18.91%
-18.91%
1 Year
-27.44%
-27.44%

More News

Read More
Week In Review: Fosun Acquires VerImmune Cancer Immunotherapy In $125 Million Deal
Via Talk Markets
Week In Review: Shanghai Regor To Discover Metabolic Therapies For Lilly In $1.55 Billion Deal
Via Talk Markets
Week In Review: Zai Lab Raises $750 Million In Private Placement For In-Licensed/Novel Drugs
Via Talk Markets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.